Grzegorz Gonda
Direktor/Vorstandsmitglied bei ICE CODE GAMES S.A.
Profil
Grzegorz Gonda currently works at ICE CODE GAMES SA, as Vice Chairman-Supervisory Board from 2017.
Mr. Gonda also formerly worked at Erne Ventures SA, as Member-Supervisory Board from 2002 to 2014, Mieszko SA, as Member-Supervisory Board from 2002 to 2014, Eficom-Sinersio SA, as Auditor-Special Affairs in 2016, Provecta IT SA, as Member-Supervisory Board from 2002 to 2014, and Bb Development SA, as Member-Supervisory Board.
Mr. Gonda received his graduate degree from the University of Lodz.
Aktive Positionen von Grzegorz Gonda
Unternehmen | Position | Beginn |
---|---|---|
ICE CODE GAMES S.A. | Direktor/Vorstandsmitglied | 26.04.2017 |
Ehemalige bekannte Positionen von Grzegorz Gonda
Unternehmen | Position | Ende |
---|---|---|
EFICOM-SINERSIO SA | Comptroller/Controller/Auditor | 01.04.2016 |
Provecta IT SA
Provecta IT SA Miscellaneous Commercial ServicesCommercial Services Provecta IT SA engages in the sale of hardware and information technology solutions. The company was founded in June 1, 2010 and is headquartered in Poznan, Poland. | Direktor/Vorstandsmitglied | 01.01.2014 |
ZAKLADY PRZEMYSLU CUKIERNICZEGO MIESZKO | Direktor/Vorstandsmitglied | 01.01.2014 |
ERNE VENTURES SA | Direktor/Vorstandsmitglied | 01.01.2014 |
Bb Development SA | Direktor/Vorstandsmitglied | - |
Ausbildung von Grzegorz Gonda
University of Lodz | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ICE CODE GAMES S.A. | Technology Services |
Private Unternehmen | 5 |
---|---|
Erne Ventures SA
Erne Ventures SA Specialty StoresRetail Trade Erne Ventures SA is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; RX-5902 or Supinoxin for metastatic triple negative breast cancer; and RX-0201 or Archexin for renal cell carcinoma, glioblastoma, ovarian, stomach, and pancreatic cancer. It also develops nano-based drug delivery systems. The company was founded by Arkadiusz Stefan Kuich in September 2007 and is headquartered in Warszawa, Poland. | Retail Trade |
Mieszko SA
Mieszko SA Food: Specialty/CandyConsumer Non-Durables Mieszko SA manufactures confectionery products. It offers candy, chocolate bars, fruit drops, fudge, and wafers. Its brands include Cherrissimo, Amoretta, Michaszki, Chocoladorro, and Magnifique. The company was founded in 1993 and is headquartered in Warsaw, Poland. | Consumer Non-Durables |
Eficom-Sinersio SA
Eficom-Sinersio SA Investment ManagersFinance Eficom-Sinersio SA provides marketing consulting services. The company was founded in 1999 and is headquartered in Warsaw, Poland. | Finance |
Provecta IT SA
Provecta IT SA Miscellaneous Commercial ServicesCommercial Services Provecta IT SA engages in the sale of hardware and information technology solutions. The company was founded in June 1, 2010 and is headquartered in Poznan, Poland. | Commercial Services |
Bb Development SA |